BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lu W, Lin C, King TD, Chen H, Reynolds RC, Li Y. Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells. Cell Signal 2012;24:2291-6. [PMID: 22820499 DOI: 10.1016/j.cellsig.2012.07.009] [Cited by in Crossref: 86] [Cited by in F6Publishing: 90] [Article Influence: 8.6] [Reference Citation Analysis]
Number Citing Articles
1 Emadi SA, Ghasemzadeh Rahbardar M, Mehri S, Hosseinzadeh H. A review of therapeutic potentials of milk thistle (Silybum marianum L.) and its main constituent, silymarin, on cancer, and their related patents. Iran J Basic Med Sci 2022;25:1166-76. [PMID: 36311193 DOI: 10.22038/IJBMS.2022.63200.13961] [Reference Citation Analysis]
2 Li Z, Peng F, Liu Z, Li S, Li L, Qian X. Mechanobiological responses of astrocytes in optic nerve head due to biaxial stretch. BMC Ophthalmol 2022;22. [DOI: 10.1186/s12886-022-02592-8] [Reference Citation Analysis]
3 Solanki R, Jodha B, Prabina KE, Aggarwal N, Patel S. Recent advances in phytochemical based nano-drug delivery systems to combat breast cancer: A review. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103832] [Reference Citation Analysis]
4 Karimi Z, Zarifkar A, Dianatpour M, Mirzaei E, Dara M, Aligholi H. Nanosilibinin ameliorates anxiety, learning impairment and Wnt-β catenin related genes expression deficits in zebrafish model of Autism Spectrum Disorder.. [DOI: 10.21203/rs.3.rs-1980576/v1] [Reference Citation Analysis]
5 Arzi L, Mollaei H, Hoshyar R. Countering Triple Negative Breast Cancer via Impeding Wnt/β-Catenin Signaling, a Phytotherapeutic Approach. Plants 2022;11:2191. [DOI: 10.3390/plants11172191] [Reference Citation Analysis]
6 Wadhwa K, Pahwa R, Kumar M, Kumar S, Sharma PC, Singh G, Verma R, Mittal V, Singh I, Kaushik D, Jeandet P. Mechanistic Insights into the Pharmacological Significance of Silymarin. Molecules 2022;27:5327. [PMID: 36014565 DOI: 10.3390/molecules27165327] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Singla RK, Wang X, Gundamaraju R, Joon S, Tsagkaris C, Behzad S, Khan J, Gautam R, Goyal R, Rakmai J, Dubey AK, Simal-Gandara J, Shen B. Natural products derived from medicinal plants and microbes might act as a game-changer in breast cancer: a comprehensive review of preclinical and clinical studies. Crit Rev Food Sci Nutr 2022;:1-45. [PMID: 35838143 DOI: 10.1080/10408398.2022.2097196] [Reference Citation Analysis]
8 Koltai T, Fliegel L. Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions. J Evid Based Integr Med 2022;27:2515690X211068826. [PMID: 35018864 DOI: 10.1177/2515690X211068826] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Zhang T, Zhou H, Wang K, Wang X, Wang M, Zhao W, Xi X, Li Y, Cai M, Zhao W, Xu Y, Shao R. Role, molecular mechanism and the potential target of breast cancer stem cells in breast cancer development. Biomed Pharmacother 2022;147:112616. [PMID: 35008001 DOI: 10.1016/j.biopha.2022.112616] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
10 Devkota HP. Nutraceutical Compounds, Classification, Biosynthesis, and Function. Nutraceuticals Production from Plant Cell Factory 2022. [DOI: 10.1007/978-981-16-8858-4_1] [Reference Citation Analysis]
11 Yassin NYS, AbouZid SF, El-Kalaawy AM, Ali TM, Almehmadi MM, Ahmed OM. Silybum marianum total extract, silymarin and silibinin abate hepatocarcinogenesis and hepatocellular carcinoma growth via modulation of the HGF/c-Met, Wnt/β-catenin, and PI3K/Akt/mTOR signaling pathways. Biomed Pharmacother 2021;145:112409. [PMID: 34781148 DOI: 10.1016/j.biopha.2021.112409] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
12 Yu W, Hu C, Gao H. Advances of nanomedicines in breast cancer metastasis treatment targeting different metastatic stages. Adv Drug Deliv Rev 2021;178:113909. [PMID: 34352354 DOI: 10.1016/j.addr.2021.113909] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 16.0] [Reference Citation Analysis]
13 Chen LJ, Lin XX, Guo J, Xu Y, Zhang SX, Chen D, Zhao Q, Xiao J, Lian GH, Peng SF, Guo D, Yang H, Shu Y, Zhou HH, Zhang W, Chen Y. Lrp6 Genotype affects Individual Susceptibility to Nonalcoholic Fatty Liver Disease and Silibinin Therapeutic Response via Wnt/β-catenin-Cyp2e1 Signaling. Int J Biol Sci 2021;17:3936-53. [PMID: 34671210 DOI: 10.7150/ijbs.63732] [Reference Citation Analysis]
14 Yassin NYS, AbouZid SF, El-Kalaawy AM, Ali TM, Elesawy BH, Ahmed OM. Tackling of Renal Carcinogenesis in Wistar Rats by Silybum marianum Total Extract, Silymarin, and Silibinin via Modulation of Oxidative Stress, Apoptosis, Nrf2, PPARγ, NF-κB, and PI3K/Akt Signaling Pathways. Oxid Med Cell Longev 2021;2021:7665169. [PMID: 34630852 DOI: 10.1155/2021/7665169] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
15 Zhu H, Su Z, Ning J, Zhou L, Tan L, Sayed S, Song J, Wang Z, Li H, Sun Q, Liu S, Sha O, Leng F, Chen X, Lu D. Transmembrane protein 97 exhibits oncogenic properties via enhancing LRP6-mediated Wnt signaling in breast cancer. Cell Death Dis 2021;12:912. [PMID: 34615853 DOI: 10.1038/s41419-021-04211-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
16 Zhang Y, Shu C, Maimaiti Y, Wang S, Lu C, Zhou J. LRP6 as a biomarker of poor prognosis of breast cancer. Gland Surg 2021;10:2414-27. [PMID: 34527553 DOI: 10.21037/gs-21-194] [Reference Citation Analysis]
17 Yu F, Yu C, Li F, Zuo Y, Wang Y, Yao L, Wu C, Wang C, Ye L. Wnt/β-catenin signaling in cancers and targeted therapies. Signal Transduct Target Ther 2021;6:307. [PMID: 34456337 DOI: 10.1038/s41392-021-00701-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 31] [Article Influence: 25.0] [Reference Citation Analysis]
18 Karami K, Anbari K. Breast Cancer: A Review of Risk Factors and New Insights into Treatment. CCTR 2021;17:207-33. [DOI: 10.2174/1573394717999210120195208] [Reference Citation Analysis]
19 Poltavets YI, Kuznetsov SL, Tubasheva IA, Murav’eva AI, Gukasova NV. Nano- and Microsized Forms of Silymarin and Silybin. Nanotechnol Russia 2021;16:115-37. [DOI: 10.1134/s2635167621020105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Binienda A, Ziolkowska S, Pluciennik E. The Anticancer Properties of Silibinin: Its Molecular Mechanism and Therapeutic Effect in Breast Cancer. Anticancer Agents Med Chem 2020;20:1787-96. [PMID: 31858905 DOI: 10.2174/1871520620666191220142741] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
21 Azbazdar Y, Karabicici M, Erdal E, Ozhan G. Regulation of Wnt Signaling Pathways at the Plasma Membrane and Their Misregulation in Cancer. Front Cell Dev Biol 2021;9:631623. [PMID: 33585487 DOI: 10.3389/fcell.2021.631623] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 24.0] [Reference Citation Analysis]
22 Koltai T, Reshkin SJ, Baltazar F, Fliegel L. Lipid metabolism part I. Prostate Cancer Metabolism 2021. [DOI: 10.1016/b978-0-323-90528-2.00013-8] [Reference Citation Analysis]
23 Das A, Banik BK. Microwave-assisted oxidation and reduction reactions. Microwaves in Chemistry Applications 2021. [DOI: 10.1016/b978-0-12-822895-1.00001-1] [Reference Citation Analysis]
24 Elyasi S. Silybum marianum, antioxidant activity, and cancer patients. Cancer 2021. [DOI: 10.1016/b978-0-12-819547-5.00043-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Hussain A, Bourguet-kondracki M, Hussain F, Rauf A, Ibrahim M, Khalid M, Hussain H, Hussain J, Ali I, Khalil AA, Alhumaydhi FA, Khan M, Hussain R, Rengasamy KRR. The potential role of dietary plant ingredients against mammary cancer: a comprehensive review. Critical Reviews in Food Science and Nutrition. [DOI: 10.1080/10408398.2020.1855413] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
26 Mukherjee N, Panda CK. Wnt/β-Catenin Signaling Pathway as Chemotherapeutic Target in Breast Cancer: An Update on Pros and Cons. Clinical Breast Cancer 2020;20:361-70. [DOI: 10.1016/j.clbc.2020.04.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 8.5] [Reference Citation Analysis]
27 Sferrazza G, Corti M, Brusotti G, Pierimarchi P, Temporini C, Serafino A, Calleri E. Nature-derived compounds modulating Wnt/ β -catenin pathway: a preventive and therapeutic opportunity in neoplastic diseases. Acta Pharm Sin B 2020;10:1814-34. [PMID: 33163337 DOI: 10.1016/j.apsb.2019.12.019] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
28 Khan H, Belwal T, Efferth T, Farooqi AA, Sanches-Silva A, Vacca RA, Nabavi SF, Khan F, Prasad Devkota H, Barreca D, Sureda A, Tejada S, Dacrema M, Daglia M, Suntar İ, Xu S, Ullah H, Battino M, Giampieri F, Nabavi SM. Targeting epigenetics in cancer: therapeutic potential of flavonoids. Crit Rev Food Sci Nutr 2021;61:1616-39. [PMID: 32478608 DOI: 10.1080/10408398.2020.1763910] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 12.5] [Reference Citation Analysis]
29 Manandhar S, Kabekkodu SP, Pai KSR. Aberrant canonical Wnt signaling: Phytochemical based modulation. Phytomedicine 2020;76:153243. [PMID: 32535482 DOI: 10.1016/j.phymed.2020.153243] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
30 Fontana F, Raimondi M, Marzagalli M, Di Domizio A, Limonta P. Natural Compounds in Prostate Cancer Prevention and Treatment: Mechanisms of Action and Molecular Targets. Cells 2020;9:E460. [PMID: 32085497 DOI: 10.3390/cells9020460] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 16.0] [Reference Citation Analysis]
31 Yu K, Rohr J, Liu Y, Li M, Xu J, Wang K, Chai J, Zhao D, Liu Y, Ma J, Fan L, Wang Z, Guo S. Progress in triple negative breast carcinoma pathophysiology: Potential therapeutic targets. Pathol Res Pract 2020;216:152874. [PMID: 32088086 DOI: 10.1016/j.prp.2020.152874] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
32 Gan S, Ye J, Li J, Hu C, Wang J, Xu D, Pan X, Chu C, Chu J, Zhang J, Zheng J, Zhang X, Xu J, Zhang H, Qu F, Cui X. LRP11 activates β-catenin to induce PD-L1 expression in prostate cancer. J Drug Target 2020;28:508-15. [PMID: 31865764 DOI: 10.1080/1061186X.2019.1687710] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
33 Alves Pinto I, Freitas Da Silveira NJ. In Silico Identification of Potential Inhibitors of the Wnt Signaling Pathway in Human Breast Cancer. J Comput Biol 2020;27:999-1010. [PMID: 31647315 DOI: 10.1089/cmb.2019.0311] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
34 Raisch J, Côté-Biron A, Rivard N. A Role for the WNT Co-Receptor LRP6 in Pathogenesis and Therapy of Epithelial Cancers. Cancers (Basel) 2019;11:E1162. [PMID: 31412666 DOI: 10.3390/cancers11081162] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
35 Hosseinabadi T, Lorigooini Z, Tabarzad M, Salehi B, Rodrigues CF, Martins N, Sharifi‐rad J. Silymarin antiproliferative and apoptotic effects: Insights into its clinical impact in various types of cancer. Phytotherapy Research 2019;33:2849-61. [DOI: 10.1002/ptr.6470] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 7.7] [Reference Citation Analysis]
36 Hussain A, Dar MS, Bano N, Hossain MM, Basit R, Bhat AQ, Aga MA, Ali S, Hassan QP, Dar MJ. Identification of dinactin, a macrolide antibiotic, as a natural product-based small molecule targeting Wnt/β-catenin signaling pathway in cancer cells. Cancer Chemother Pharmacol 2019;84:551-9. [PMID: 31129716 DOI: 10.1007/s00280-019-03870-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
37 Mishra S, Verma SS, Rai V, Awasthee N, Chava S, Hui KM, Kumar AP, Challagundla KB, Sethi G, Gupta SC. Long non-coding RNAs are emerging targets of phytochemicals for cancer and other chronic diseases. Cell Mol Life Sci 2019;76:1947-66. [PMID: 30879091 DOI: 10.1007/s00018-019-03053-0] [Cited by in Crossref: 136] [Cited by in F6Publishing: 124] [Article Influence: 45.3] [Reference Citation Analysis]
38 Pashirzad M, Shafiee M, Khazaei M, Fiuji H, Ryzhikov M, Soleimanpour S, Hesari A, Avan A, Hassanian SM. Therapeutic potency of Wnt signaling antagonists in the pathogenesis of prostate cancer, current status and perspectives. J Cell Physiol 2019;234:1237-47. [PMID: 30191954 DOI: 10.1002/jcp.27137] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
39 Amawi H, Hussein NA, Ashby CR Jr, Alnafisah R, Sanglard LM, Manivannan E, Karthikeyan C, Trivedi P, Eisenmann KM, Robey RW, Tiwari AK. Bax/Tubulin/Epithelial-Mesenchymal Pathways Determine the Efficacy of Silybin Analog HM015k in Colorectal Cancer Cell Growth and Metastasis. Front Pharmacol 2018;9:520. [PMID: 29875662 DOI: 10.3389/fphar.2018.00520] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
40 Bryukhovetskiy I, Ponomarenko A, Lyakhova I, Zaitsev S, Zayats Y, Korneyko M, Eliseikina M, Mischenko P, Shevchenko V, Shanker Sharma H, Sharma A, Khotimchenko Y. Personalized regulation of glioblastoma cancer stem cells based on biomedical technologies: From theory to experiment (Review). Int J Mol Med 2018;42:691-702. [PMID: 29749540 DOI: 10.3892/ijmm.2018.3668] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
41 Mitra S, Dash R. Natural Products for the Management and Prevention of Breast Cancer. Evid Based Complement Alternat Med 2018;2018:8324696. [PMID: 29681985 DOI: 10.1155/2018/8324696] [Cited by in Crossref: 92] [Cited by in F6Publishing: 103] [Article Influence: 23.0] [Reference Citation Analysis]
42 Yu S, Wang Z, Su Z, Song J, Zhou L, Sun Q, Liu S, Li S, Li Y, Wang M, Zhang GQ, Zhang X, Liu ZJ, Lu D. Gigantol inhibits Wnt/β-catenin signaling and exhibits anticancer activity in breast cancer cells. BMC Complement Altern Med 2018;18:59. [PMID: 29444668 DOI: 10.1186/s12906-018-2108-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 6.3] [Reference Citation Analysis]
43 Foulquier S, Daskalopoulos EP, Lluri G, Hermans KCM, Deb A, Blankesteijn WM. WNT Signaling in Cardiac and Vascular Disease. Pharmacol Rev 2018;70:68-141. [PMID: 29247129 DOI: 10.1124/pr.117.013896] [Cited by in Crossref: 166] [Cited by in F6Publishing: 178] [Article Influence: 41.5] [Reference Citation Analysis]
44 Younas M, Hano C, Giglioli-guivarc'h N, Abbasi BH. Mechanistic evaluation of phytochemicals in breast cancer remedy: current understanding and future perspectives. RSC Adv 2018;8:29714-44. [DOI: 10.1039/c8ra04879g] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 8.0] [Reference Citation Analysis]
45 Kandhari K, Agraval H, Sharma A, Yadav UCS, Singh RP. Flavonoids and Cancer Stem Cells Maintenance and Growth. Functional Food and Human Health 2018. [DOI: 10.1007/978-981-13-1123-9_26] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
46 Miller-Kleinhenz J, Guo X, Qian W, Zhou H, Bozeman EN, Zhu L, Ji X, Wang YA, Styblo T, O'Regan R, Mao H, Yang L. Dual-targeting Wnt and uPA receptors using peptide conjugated ultra-small nanoparticle drug carriers inhibited cancer stem-cell phenotype in chemo-resistant breast cancer. Biomaterials 2018;152:47-62. [PMID: 29107218 DOI: 10.1016/j.biomaterials.2017.10.035] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 9.4] [Reference Citation Analysis]
47 Fang Y, Kang Y, Zou H, Cheng X, Xie T, Shi L, Zhang H. β-elemene attenuates macrophage activation and proinflammatory factor production via crosstalk with Wnt/β-catenin signaling pathway. Fitoterapia 2018;124:92-102. [PMID: 29066299 DOI: 10.1016/j.fitote.2017.10.015] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
48 Imai-Sumida M, Chiyomaru T, Majid S, Saini S, Nip H, Dahiya R, Tanaka Y, Yamamura S. Silibinin suppresses bladder cancer through down-regulation of actin cytoskeleton and PI3K/Akt signaling pathways. Oncotarget 2017;8:92032-42. [PMID: 29190895 DOI: 10.18632/oncotarget.20734] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
49 Wu N, Zhang YL, Wang HT, Li DW, Dai HJ, Zhang QQ, Zhang J, Ma Y, Xia Q, Bian JM, Hang HL. Overexpression of hepatocyte nuclear factor 4α in human mesenchymal stem cells suppresses hepatocellular carcinoma development through Wnt/β-catenin signaling pathway downregulation. Cancer Biol Ther 2016;17:558-65. [PMID: 27124543 DOI: 10.1080/15384047.2016.1177675] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 6.4] [Reference Citation Analysis]
50 Mathew B, Hobrath JV, Lu W, Li Y, Reynolds RC. Synthesis and preliminary assessment of the anticancer and Wnt/β-catenin inhibitory activity of small amide libraries of fenamates and profens. Med Chem Res 2017;26:3038-45. [PMID: 29104411 DOI: 10.1007/s00044-017-2001-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
51 Amawi H, Hussein NA, Karthikeyan C, Manivannan E, Wisner A, Williams FE, Samuel T, Trivedi P, Ashby CR Jr, Tiwari AK. HM015k, a Novel Silybin Derivative, Multi-Targets Metastatic Ovarian Cancer Cells and Is Safe in Zebrafish Toxicity Studies. Front Pharmacol 2017;8:498. [PMID: 28824426 DOI: 10.3389/fphar.2017.00498] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
52 Li Q, Ye L, Guo W, Wang M, Huang S, Peng X. PHF21B overexpression promotes cancer stem cell-like traits in prostate cancer cells by activating the Wnt/β-catenin signaling pathway. J Exp Clin Cancer Res 2017;36:85. [PMID: 28645312 DOI: 10.1186/s13046-017-0560-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
53 Zhang Y. Ganoderma lucidum (Reishi) suppresses proliferation and migration of breast cancer cells via inhibiting Wnt/β-catenin signaling. Biochem Biophys Res Commun 2017;488:679-84. [PMID: 28427938 DOI: 10.1016/j.bbrc.2017.04.086] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 6.4] [Reference Citation Analysis]
54 Li Y, Oliver PG, Lu W, Pathak V, Sridharan S, Augelli-Szafran CE, Buchsbaum DJ, Suto MJ. SRI36160 is a specific inhibitor of Wnt/β-catenin signaling in human pancreatic and colorectal cancer cells. Cancer Lett 2017;389:41-8. [PMID: 28043913 DOI: 10.1016/j.canlet.2016.12.030] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
55 Polachi N, Bai G, Li T, Chu Y, Wang X, Li S, Gu N, Wu J, Li W, Zhang Y, Zhou S, Sun H, Liu C. Modulatory effects of silibinin in various cell signaling pathways against liver disorders and cancer – A comprehensive review. European Journal of Medicinal Chemistry 2016;123:577-95. [DOI: 10.1016/j.ejmech.2016.07.070] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 7.5] [Reference Citation Analysis]
56 Undi RB, Gutti U, Gutti RK. LiCl regulates mitochondrial biogenesis during megakaryocyte development. J Trace Elem Med Biol 2017;39:193-201. [PMID: 27908414 DOI: 10.1016/j.jtemb.2016.10.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
57 Lin W, Li J, Zhang B, Liu L, Zou Y, Tan J, Li H. MicroRNA-1301 induces cell proliferation by downregulating ICAT expression in breast cancer. Biomedicine & Pharmacotherapy 2016;83:177-85. [DOI: 10.1016/j.biopha.2016.06.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
58 Chang YC, Jan CI, Peng CY, Lai YC, Hu FW, Yu CC. Activation of microRNA-494-targeting Bmi1 and ADAM10 by silibinin ablates cancer stemness and predicts favourable prognostic value in head and neck squamous cell carcinomas. Oncotarget 2015;6:24002-16. [PMID: 26090866 DOI: 10.18632/oncotarget.4365] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 7.2] [Reference Citation Analysis]
59 Zhu XX, Ding YH, Wu Y, Qian LY, Zou H, He Q. Silibinin: a potential old drug for cancer therapy. Expert Rev Clin Pharmacol. 2016; 18: 1-8 Epub ahead of print. [PMID: 27362364 DOI: 10.1080/17512433.2016.1208563] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
60 Eo HJ, Park GH, Jeong JB. Inhibition of Wnt Signaling by Silymarin in Human Colorectal Cancer Cells. Biomol Ther (Seoul) 2016;24:380-6. [PMID: 27068260 DOI: 10.4062/biomolther.2015.154] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
61 Yang J, Chen J, He J, Li J, Shi J, Cho WC, Liu X. Wnt signaling as potential therapeutic target in lung cancer. Expert Opin Ther Targets 2016;20:999-1015. [PMID: 26882052 DOI: 10.1517/14728222.2016.1154945] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 5.8] [Reference Citation Analysis]
62 Li F, Zhang L, Li W, Deng J, Zheng J, An M, Lu J, Zhou Y. Circular RNA ITCH has inhibitory effect on ESCC by suppressing the Wnt/β-catenin pathway. Oncotarget. 2015;6:6001-6013. [PMID: 25749389 DOI: 10.18632/oncotarget.3469] [Cited by in Crossref: 449] [Cited by in F6Publishing: 530] [Article Influence: 74.8] [Reference Citation Analysis]
63 Masuda M, Sawa M, Yamada T. Therapeutic targets in the Wnt signaling pathway: Feasibility of targeting TNIK in colorectal cancer. Pharmacology & Therapeutics 2015;156:1-9. [DOI: 10.1016/j.pharmthera.2015.10.009] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 7.1] [Reference Citation Analysis]
64 Yang K, Wang X, Zhang H, Wang Z, Nan G, Li Y, Zhang F, Mohammed MK, Haydon RC, Luu HH, Bi Y, He TC. The evolving roles of canonical WNT signaling in stem cells and tumorigenesis: implications in targeted cancer therapies. Lab Invest 2016;96:116-36. [PMID: 26618721 DOI: 10.1038/labinvest.2015.144] [Cited by in Crossref: 131] [Cited by in F6Publishing: 140] [Article Influence: 18.7] [Reference Citation Analysis]
65 Guimarães DM, Antunes DM, Saturno JL, Massuda F, Paiva KB, Nunes FD. Immunohistochemical expression of WNT5A and MMPs in odontogenic epithelial tumors and cysts. Acta Histochem 2015;117:667-74. [PMID: 26558991 DOI: 10.1016/j.acthis.2015.10.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
66 He S, Lu Y, Liu X, Huang X, Keller ET, Qian CN, Zhang J. Wnt3a: functions and implications in cancer. Chin J Cancer 2015;34:554-62. [PMID: 26369691 DOI: 10.1186/s40880-015-0052-4] [Cited by in Crossref: 33] [Cited by in F6Publishing: 43] [Article Influence: 4.7] [Reference Citation Analysis]
67 Lu W, Li Y. Salinomycin suppresses LRP6 expression and inhibits both Wnt/β-catenin and mTORC1 signaling in breast and prostate cancer cells. J Cell Biochem. 2014;115:1799-1807. [PMID: 24905570 DOI: 10.1002/jcb.24850] [Cited by in Crossref: 68] [Cited by in F6Publishing: 72] [Article Influence: 9.7] [Reference Citation Analysis]
68 Zanni R, Galvez-Llompart M, Morell C, Rodríguez-Henche N, Díaz-Laviada I, Recio-Iglesias MC, Garcia-Domenech R, Galvez J. Novel cancer chemotherapy hits by molecular topology: dual Akt and Beta-catenin inhibitors. PLoS One 2015;10:e0124244. [PMID: 25910265 DOI: 10.1371/journal.pone.0124244] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
69 Liu Z, Sun B, Qi L, Li Y, Zhao X, Zhang D, Zhang Y. Dickkopf-1 expression is down-regulated during the colorectal adenoma-carcinoma sequence and correlates with reduced microvessel density and VEGF expression. Histopathology 2015;67:158-66. [DOI: 10.1111/his.12474] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
70 Patel S. A Promising CAM Therapeutic For Multiple Cancers: Milk Thistle (Silybum). Emerging Bioresources with Nutraceutical and Pharmaceutical Prospects 2015. [DOI: 10.1007/978-3-319-12847-4_10] [Reference Citation Analysis]
71 Huang C, Chen YJ, Chen W, Lin C, Wei YX, Huang HC. Combined treatment with chrysin and 1,2,3,4,6-penta-O-galloyl-β-D-glucose synergistically inhibits LRP6 and Skp2 activation in triple-negative breast cancer and xenografts: SYNERGISTICALLY INHIBITS LRP6 AND Skp2 ACTIVATION. Mol Carcinog 2015;54:1613-25. [DOI: 10.1002/mc.22234] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
72 Zarrelli A, Romanucci V, Tuccillo C, Federico A, Loguercio C, Gravante R, Di Fabio G. New silibinin glyco-conjugates: synthesis and evaluation of antioxidant properties. Bioorg Med Chem Lett 2014;24:5147-9. [PMID: 25442301 DOI: 10.1016/j.bmcl.2014.10.023] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
73 Hara K, Kageji T, Mizobuchi Y, Kitazato KT, Okazaki T, Fujihara T, Nakajima K, Mure H, Kuwayama K, Hara T, Nagahiro S. Blocking of the interaction between Wnt proteins and their co-receptors contributes to the anti-tumor effects of adenovirus-mediated DKK3 in glioblastoma. Cancer Lett 2015;356:496-505. [PMID: 25301448 DOI: 10.1016/j.canlet.2014.09.045] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
74 Rodriguez JP, Coulter M, Miotke J, Meyer RL, Takemaru K, Levine JM. Abrogation of β-catenin signaling in oligodendrocyte precursor cells reduces glial scarring and promotes axon regeneration after CNS injury. J Neurosci 2014;34:10285-97. [PMID: 25080590 DOI: 10.1523/JNEUROSCI.4915-13.2014] [Cited by in Crossref: 62] [Cited by in F6Publishing: 69] [Article Influence: 7.8] [Reference Citation Analysis]
75 Lu W, Lin C, Li Y. Rottlerin induces Wnt co-receptor LRP6 degradation and suppresses both Wnt/β-catenin and mTORC1 signaling in prostate and breast cancer cells. Cell Signal. 2014;26:1303-1309. [PMID: 24607787 DOI: 10.1016/j.cellsig.2014.02.018] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 5.1] [Reference Citation Analysis]
76 Ting H, Deep G, Agarwal C, Agarwal R. The strategies to control prostate cancer by chemoprevention approaches. Mutat Res 2014;760:1-15. [PMID: 24389535 DOI: 10.1016/j.mrfmmm.2013.12.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
77 Zhang R, Nag S. Nutraceuticals in Preventive Oncology: Chemical Biology and Translational Pharmaceutical Science. Pharma-Nutrition 2014. [DOI: 10.1007/978-3-319-06151-1_16] [Reference Citation Analysis]
78 Li H, Lee HJ, Ahn YH, Kwon HJ, Jang C, Kim W, Ryu J. Tussilagone suppresses colon cancer cell proliferation by promoting the degradation of β-catenin. Biochemical and Biophysical Research Communications 2014;443:132-7. [DOI: 10.1016/j.bbrc.2013.11.062] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
79 Milić N, Milošević N, Suvajdžić L, Žarkov M, Abenavoli L. New Therapeutic Potentials of Milk Thistle ( Silybum marianum ). Natural Product Communications 2013;8:1934578X1300801. [DOI: 10.1177/1934578x1300801236] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
80 Di Fabio G, Romanucci V, De Nisco M, Pedatella S, Di Marino C, Zarrelli A. Microwave-assisted oxidation of silibinin: a simple and preparative method for the synthesis of improved radical scavengers. Tetrahedron Letters 2013;54:6279-82. [DOI: 10.1016/j.tetlet.2013.09.035] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
81 Zhang Y, Yang DH, Zhang YT, Chen XM, Li LL, Cai SQ. Biotransformation on the flavonolignan constituents of Silybi Fructus by an intestinal bacterial strain Eubacterium limosum ZL-II. Fitoterapia 2014;92:61-71. [PMID: 24125915 DOI: 10.1016/j.fitote.2013.10.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
82 Pez F, Lopez A, Kim M, Wands JR, Caron de Fromentel C, Merle P. Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs. J Hepatol 2013;59:1107-17. [PMID: 23835194 DOI: 10.1016/j.jhep.2013.07.001] [Cited by in Crossref: 191] [Cited by in F6Publishing: 202] [Article Influence: 21.2] [Reference Citation Analysis]
83 Ting H, Deep G, Agarwal R. Molecular mechanisms of silibinin-mediated cancer chemoprevention with major emphasis on prostate cancer. AAPS J 2013;15:707-16. [PMID: 23588585 DOI: 10.1208/s12248-013-9486-2] [Cited by in Crossref: 56] [Cited by in F6Publishing: 44] [Article Influence: 6.2] [Reference Citation Analysis]
84 Fayyaz S, Farooqi AA. miRNA and TMPRSS2-ERG do not mind their own business in prostate cancer cells. Immunogenetics 2013;65:315-32. [DOI: 10.1007/s00251-012-0677-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
85 Baarsma HA, Königshoff M, Gosens R. The WNT signaling pathway from ligand secretion to gene transcription: molecular mechanisms and pharmacological targets. Pharmacol Ther. 2013;138:66-83. [PMID: 23328704 DOI: 10.1016/j.pharmthera.2013.01.002] [Cited by in Crossref: 119] [Cited by in F6Publishing: 121] [Article Influence: 13.2] [Reference Citation Analysis]
86 Moorthi C, Kathiresan K. Curcumin–Piperine/Curcumin–Quercetin/Curcumin–Silibinin dual drug-loaded nanoparticulate combination therapy: A novel approach to target and treat multidrug-resistant cancers. Journal of Medical Hypotheses and Ideas 2013;7:15-20. [DOI: 10.1016/j.jmhi.2012.10.005] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 4.1] [Reference Citation Analysis]